首页> 美国卫生研究院文献>Blood >BCAP inhibits proliferation and differentiation of myeloid progenitors in the steady state and during demand situations
【2h】

BCAP inhibits proliferation and differentiation of myeloid progenitors in the steady state and during demand situations

机译:BCAP在稳态和需求情况下抑制骨髓祖细胞的增殖和分化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

B-cell adaptor for phosphatidylinositol 3-kinase (BCAP) is a signaling adaptor expressed in mature hematopoietic cells, including monocytes and neutrophils. Here we investigated the role of BCAP in the homeostasis and development of these myeloid lineages. BCAP−/− mice had more bone marrow (BM) monocytes than wild-type (WT) mice, and in mixed WT:BCAP−/− BM chimeras, monocytes and neutrophils skewed toward BCAP−/− origin, showing a competitive advantage for BCAP−/− myeloid cells. BCAP was expressed in BM hematopoietic progenitors, including lineageSca-1+c-kit+ (LSK), common myeloid progenitor, and granulocyte/macrophage progenitor (GMP) cells. At the steady state, BCAP−/− GMP cells expressed more IRF8 and less C/EBPα than did WT GMP cells, which correlated with an increase in monocyte progenitors and a decrease in granulocyte progenitors among GMP cells. Strikingly, BCAP−/− progenitors proliferated and produced more myeloid cells of both neutrophil and monocyte/macrophage lineages than did WT progenitors in myeloid colony-forming unit assays, supporting a cell-intrinsic role of BCAP in inhibiting myeloid proliferation and differentiation. Consistent with these findings, during cyclophosphamide-induced myeloablation or specific monocyte depletion, BCAP−/− mice replenished circulating monocytes and neutrophils earlier than WT mice. During myeloid replenishment after cyclophosphamide-induced myeloablation, BCAP−/− mice had increased LSK proliferation and increased numbers of LSK and GMP cells compared with WT mice. Furthermore, BCAP−/− mice accumulated more monocytes and neutrophils in the spleen than did WT mice during Listeria monocytogenes infection. Together, these data identify BCAP as a novel inhibitor of myelopoiesis in the steady state and of emergency myelopoiesis during demand conditions.
机译:磷脂酰肌醇3激酶(BCAP)的B细胞衔接子是在成熟的造血细胞(包括单核细胞和嗜中性粒细胞)中表达的信号衔接子。在这里,我们研究了BCAP在这些髓系谱系的稳态和发育中的作用。 BCAP -/-小鼠的骨髓(BM)单核细胞比野生型(WT)小鼠多,并且在混合WT:BCAP -/- BM嵌合体,单核细胞和中性粒细胞偏向BCAP -/-来源,显示出对BCAP -/-髓样细胞的竞争优势。 BCAP在BM造血祖细胞中表达,包括血统- Sca-1 + c-kit + (LSK),普通骨髓祖细胞和粒细胞/巨噬细胞祖细胞(GMP)。在稳定状态下,BCAP -/- GMP细胞比WT GMP细胞表达更多的IRF8和更少的C /EBPα,这与GMP细胞中单核细胞祖细胞的增加和粒细胞祖细胞的减少有关。令人惊讶的是,与髓样集落形成单位测定中的WT祖细胞相比,BCAP -/-祖细胞增殖并产生的嗜中性粒细胞和单核/巨噬细胞谱系的髓样细胞更多,这支持了BCAP在抑制细胞内在作用骨髓增殖和分化。与这些发现一致的是,在环磷酰胺诱导的骨髓消融或特定单核细胞耗竭期间,BCAP -/-小鼠比WT小鼠更早补充循环单核细胞和中性粒细胞。与野生型小鼠相比,在环磷酰胺诱导的骨髓消融后的骨髓补充过程中,BCAP -/-小鼠的LSK增殖增加,LSK和GMP细胞数量增加。此外,在单核细胞增生性李斯特菌感染期间,BCAP -/-小鼠的脾脏中的单核细胞和中性粒细胞的积累比野生型小鼠多。综合起来,这些数据确定了BCAP是稳定状态下的骨髓生成的新抑制剂和需求条件下的紧急骨髓生成的抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号